Cargando…
Analyzing Vaccine Trials in Epidemics With Mild and Asymptomatic Infection
Vaccine efficacy against susceptibility to infection (VE(S)), regardless of symptoms, is an important endpoint of vaccine trials for pathogens with a high proportion of asymptomatic infection, because such infections may contribute to onward transmission and long-term sequelae, such as congenital Zi...
Autores principales: | Kahn, Rebecca, Hitchings, Matt, Wang, Rui, Bellan, Steven E, Lipsitch, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357804/ https://www.ncbi.nlm.nih.gov/pubmed/30329134 http://dx.doi.org/10.1093/aje/kwy239 |
Ejemplares similares
-
Potential Biases Arising From Epidemic Dynamics in Observational Seroprotection Studies
por: Kahn, Rebecca, et al.
Publicado: (2020) -
Choices in vaccine trial design in epidemics of emerging infections
por: Kahn, Rebecca, et al.
Publicado: (2018) -
Using simulation to aid trial design: Ring-vaccination trials
por: Hitchings, Matt David Thomas, et al.
Publicado: (2017) -
Shared Genomic Variants: Identification of Transmission Routes Using Pathogen Deep-Sequence Data
por: Worby, Colin J, et al.
Publicado: (2017) -
The Usefulness of the Test-Positive Proportion of Severe Acute Respiratory Syndrome Coronavirus 2 as a Surveillance Tool
por: Hitchings, Matt D T, et al.
Publicado: (2021)